Coronary atherosclerosis in cardiac transplant patients treated with total lymphoid irradiation

Journal of Heart and Lung Transplantation

Volumn 22, Issue 2, 2003, Pages 124-129

  Pelletier, Marc P ^a   Coady, Michael A ^a   Macha, Mahender ^a   Oyer, Philip E ^a   Robbins, Robert C ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; STEROID; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CYTOMEGALOVIRUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART GRAFT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; LYMPH NODE IRRADIATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 0037311998     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00493-X     Document Type: Article

References (20)

1. Kirklin J.K., Naftel D.C., McGiffin D.C., McVay R.F., Blackstone E.H., Karp R.B. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol. 11:1988;917-924.
2. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The registry of the International Society for Heart and Lung Transplantation seventeenth official report - 2000. J Heart Lung Transplant. 19:2000;909-931.
3. Weis M., von Scheidt W. Cardiac allograft vasculopathy a review. Circulation. 96:1997;2069-2077.
4. Carrier M., Rivard M., Kostuk W., et al. The Canadian Study of Cardiac Transplantation Atherosclerosis investigators of the CASCADE Study. Can J Cardiol. 15:1999;1337-1344.
5. Mehra M.R., Ventura H.O., Chamber R.B., Ramireddy K., Smart F.W., Stapleton D.D. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy time for a reappraisal. J Heart Lung Transplant. 16:1997;743-751.
6. Hunt S.A., Strober S., Hoppe R.T., Stinson E.B. Total lymphoid irradiation for treatment of intractable cardiac allograft rejection. J Heart Lung Transplant. 10:1991;211-216.
7. Ross H.J., Gullestad L., Pak J., Slauson S., Valantine H.A., Hunt S.A. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection a comparative study. J Heart Lung Transplant. 16:1997;179-189.
8. Salter S.P., Salter M.M., Kirklin J.K., Bourge R.C., Naftel D.C. Total lymphoid irradiation in the treatment of early or recurrent heart transplant rejection. Int J Radiat Oncol Biol Phys. 33:1995;83-88.
9. Salter M.M., Kirklin J.K., Bourge R.C., et al. Total lymphoid irradiation in the treatment of early or recurrent heart rejection. J Heart Lung Transplant. 11:1992;902-911.
10. Evans M.A., Schomberg P.J., Rodeheffer R.J., et al. Total lymphoid irradiation a novel and successful therapy for resistant cardiac allograft rejection. Mayo Clin Proc. 67:1992;785-790.
11. Trachiotis G.D., Johnston T.S., Vega J.D., et al. Single-field total lymphoid irradiation in the treatment of refractory rejection after heart transplantation. J Heart Lung Transplant. 17:1998;1045-1048.
12. Wolden S.L., Tate D.J., Hunt S.A., Strober S., Hoppe R.T. Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection. Int J Radiat Oncol Biol Phys. 39:1997;953-960.
13. Keogh A., Morgan G., MacDonald P., Spratt P., Mundy J., McCosker C. Clinical transplantation. Total lymphoid irradiation for resistant rejection after heart transplantation only moderate success medium-term. J Heart Lung Transplant. 15:1996;231-233.
14. Hunt S.A., Strober S., Hoppe R.T., Stinson E.B. Total lymphoid irradiation (TLI) in the cyclosporine era - use of TLI in resistant cardiac allograft rejection. Transplant Proc. 21:1989;1793-1795.
15. Frist W.H., Winterland W.Q., Gerhardt E.B., et al. Total lymphoid irradiation in heart transplantation adjunctive treatment for recurrent rejection. Ann Thorac Surg. 48:1989;863-864.
16. Levin B., Bohannon L., Warvariv V., Bry W., Collins G. Total lymphoid irradiation (TLI) in the cyclosporine era - use of TLI in resistant cardiac allograft rejection. Transplant Proc. 21:1989;1793-1795.
17. Emond M., Mark M.B., Davis K.B., et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation. 90:1994;2645.
18. Pahl E., Zales V.R., Fricker F.J., Addonizio L.J. Posttransplant coronary artery disease in children A multicenter national survey. Circulation. 90:1994;II56-60.
19. Teirstein P.S., Massullo V., Jani S., et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 336:1997;1697-1703.
20. Teirstein P.S., Massullo V., Jani S., et al. Three-year clinical and angiographic follow-up after intracoronary radiation results of a randomized clinical trial. Circulation. 101:2000;360-365.